- Home
- FICO vs ALC Comparison
FICO vs ALC Comparison
Compare FICO & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FICO
- ALC
- Stock Information
- Founded
- FICO 1956
- ALC 1945
- Country
- FICO United States
- ALC Switzerland
- Employees
- FICO N/A
- ALC N/A
- Industry
- FICO Business Services
- ALC Ophthalmic Goods
- Sector
- FICO Consumer Discretionary
- ALC Health Care
- Exchange
- FICO Nasdaq
- ALC Nasdaq
- Market Cap
- FICO 46.4B
- ALC 47.0B
- IPO Year
- FICO 1987
- ALC N/A
- Fundamental
- Price
- FICO $1,866.03
- ALC $92.70
- Analyst Decision
- FICO Buy
- ALC Buy
- Analyst Count
- FICO 13
- ALC 12
- Target Price
- FICO $2,099.69
- ALC $105.60
- AVG Volume (30 Days)
- FICO 175.7K
- ALC 1.4M
- Earning Date
- FICO 04-24-2025
- ALC 05-12-2025
- Dividend Yield
- FICO N/A
- ALC 0.29%
- EPS Growth
- FICO 21.78
- ALC 4.59
- EPS
- FICO 21.79
- ALC 2.05
- Revenue
- FICO $1,775,435,000.00
- ALC $9,911,000,000.00
- Revenue This Year
- FICO $17.84
- ALC $6.19
- Revenue Next Year
- FICO $15.56
- ALC $7.00
- P/E Ratio
- FICO $85.76
- ALC $45.74
- Revenue Growth
- FICO 14.49
- ALC 4.82
- 52 Week Low
- FICO $1,105.65
- ALC $77.54
- 52 Week High
- FICO $2,402.52
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- FICO 52.60
- ALC 52.28
- Support Level
- FICO $1,784.61
- ALC $90.64
- Resistance Level
- FICO $1,925.00
- ALC $97.40
- Average True Range (ATR)
- FICO 50.07
- ALC 1.39
- MACD
- FICO 4.23
- ALC 0.33
- Stochastic Oscillator
- FICO 71.15
- ALC 55.82
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.